文献速递前列腺癌

前列腺癌根治术中前列腺尖部与膀胱颈软组织切缘由阳性转为阴性对肿瘤学结局的影响

The impact on oncological outcomes after radical prostatectomy for prostate cancer of converting soft tissue margins at the apex and bladder neck from tumour-positive to -negative.
PubMed 文献 · BJU Int · 2018-07-26

结果显示,将尖部与膀胱颈软组织切缘由组织学阳性转为阴性可改善生化无复发生存率和远处无转移生存率,但高风险患者中未见明显获益。

要点

  • 切缘阳性转为阴性者的5年生化无复发生存率高于持续阳性者(85.1% vs 57.1%)。
  • 在pT3期患者中,切缘转阴组的7年远处无转移生存率显著高于持续阳性组(98.0% vs 86.7%)。
  • 高风险患者中切缘转阴的获益不明显。

核心结论

  • 将前列腺尖部与膀胱颈软组织切缘由组织学阳性转为阴性可改善生化无复发生存率和远处无转移生存率。
  • 高风险患者中切缘转阴的获益不明显。

研究设计与样本

  • 根据切缘状态分为阴性切缘组、阳性转为阴性组和持续阳性组。

主要发现

  • 阴性切缘、阳性转为阴性、持续阳性组的比例分别为75.1%、4.9%、20.0%。
  • 三组5年生化无复发生存率分别为89.6%、85.1%、57.1%(P < 0.001)。
  • 三组7年远处无转移生存率分别为97.8%、99.1%、89.4%(P < 0.001)。
  • 在pT3期患者中,阳性转为阴性组的7年远处无转移生存率显著高于持续阳性组(98.0% vs 86.7%;P = 0.023),而pT2期患者中无显著差异(100% vs 96.9%;P = 0.616)。
  • 低危和中危患者中阳性转为阴性组的5年生化无复发生存率与阴性切缘组无显著差异(低危96.3% vs 95.8%;中危91.1% vs 82.8%),但高危患者中阳性转为阴性组低于阴性切缘组(73.2% vs 54.7%)。

临床怎么用

  • 对于前列腺尖部或膀胱颈切缘阳性的患者,行进一步切除以达到组织学阴性可能改善肿瘤学结局。
  • 高风险患者中切缘转阴的获益有限,需个体化评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To assess the impact of conversion from histologically positive to negative soft tissue margins at the apex and bladder neck on biochemical recurrence-free survival (BCRFS) and distant metastasis-free survival (DMFS) after radical prostatectomy (RP) for prostate cancer. MATERIALS AND METHODS: The records of 2 013 patients who underwent RP and intra-operative frozen section (IFS) analysis between July 2007 and June 2016 were reviewed. IFS analysis of the urethra and bladder neck was performed, and if malignant or atypical cells remained, further resection with the aim of achieving histological negativity was carried out. Patients were divided into three groups according to the findings: those with a negative surgical margin (NSM), a positive surgical margin converted to negative (NCSM) and a persistent positive surgical margin (PSM). RESULTS: Among the 2 013 patients, rates of NSMs, NCSMs and PSMs were 75.1%, 4.9%, and 20.0%, respectively. The 5-year BCRFS rates of patients with NSMs, NCSMs and PSMs were 89.6%, 85.1% and 57.1%, respectively (P < 0.001). In both pathological (p)T2 and pT3 cancers, the 5-year BCRFS rate for patients with NCSMs was similar to that for patients with NSMs, and higher than for patients with PSMs. The 7-year DMFS rates of patients with NSMs, NCSMs and PSMs were 97.8%, 99.1% and 89.4%, respectively (P < 0.001). Among patients with pT3 cancers, the 7-year DMFS rate was significantly higher in the NCSM group than in the PSM group (98.0% vs 86.7%; P = 0.023), but not among those with pT2 cancers (100% vs 96.9%; P = 0.616). The 5-year BCRFS rate for the NCSM group was not significantly different from that of the NSM group among the patients with low- (96.3% vs 95.8%) and intermediate-risk disease (91.1% vs 82.8%), but was lower than that of the NSM group among patients in the high-risk group (73.2% vs 54.7%). CONCLUSIONS: Conversion of the soft tissue margin at the prostate apex and bladder neck from histologically positive to negative improved the BCRFS and DMFS after RP for prostate cancer; however, the benefit of conversion was not apparent in patients in the high-risk group.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Pak S, Park S, Kim M, et al. The impact on oncological outcomes after radical prostatectomy for prostate cancer of converting soft tissue margins at the apex and bladder neck from tumour-positive to -negative. BJU Int. 2018. PMID: 29978558. doi:10.1111/bju.14480

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。